Intensive glucose control offers no benefit after kidney transplant

11/5/2012 | Modern Medicine

Researchers found statistically similar rates of delayed graft function following kidney transplant in diabetes patients receiving intensive glucose control and a control group. The study in the Journal of Clinical Endocrinology & Metabolism also found an blood glucose target of less than 180 mg/dL was associated with a lower risk of organ rejection than targets of 70-110 mg/dL, suggesting tight glycemic control may offer no help immediately after the procedure.

View Full Article in:

Modern Medicine

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Behavioral Health Operations
Meridian Health Plan
Detroit, MI
Medical Director
PacificSource
Bend, OR
Clinical Appeals RN
MJHS
Brooklyn, NY
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ